MAFA
PFE icon

MJT & Associates Financial Advisory’s Pfizer PFE Stock Holding History

MJT & Associates Financial Advisory’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.28K Hold
115
– – ﹤0.01% 314
2026
Q2 		$2.77K Hold
115
– – ﹤0.01% 357
2026
Q1 		$3.23K Hold
115
– – ﹤0.01% 326
2025
Q4 		$2.86K Hold
115
– – ﹤0.01% 360
2025
Q3 		$2.93K Hold
115
– – ﹤0.01% 360
2025
Q2 		$2.79K Hold
115
– – ﹤0.01% 374
2025
Q1 		$2.92K Buy
+115
New +$3.01K ﹤0.01% 368

Other funds holding PFE

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
RT
Rockland Trust Hanover, Massachusetts $2.61B AUM 14.26% 1-Year Est. Return
WF
WoodTrust Financial Wisconsin Rapids, Wisconsin $825M AUM 20.13% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $984M AUM 41.12% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return

MJT & Associates Financial Advisory's PFE Position: Q3 2026 in Review

MJT & Associates Financial Advisory held its Pfizer (PFE) position steady in Q3 2026 at 115 shares worth $3.28K. The position accounts for ﹤0.01% of the portfolio, ranked #314.

MJT & Associates Financial Advisory first reported a position in PFE in Q1 2025 and has held it in 7 quarters since. 156 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • MJT & Associates Financial Advisory held 115 shares of Pfizer worth $3.28K as of Q3 2026.
  • MJT & Associates Financial Advisory left its Pfizer share count unchanged in Q3 2026.
  • Pfizer made up ﹤0.01% of MJT & Associates Financial Advisory's portfolio in Q3 2026, its #314 holding.
  • MJT & Associates Financial Advisory first reported a position in Pfizer in Q1 2025 and has held it in 7 quarters since.
  • 156 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on MJT & Associates Financial Advisory's 13F filing for Q3 2026, filed 7 Oct 2026.